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Background. This study compared quality of life, depression, and healthcare resource utilization among adults with type 2 diabetes
mellitus (T2DM) and comorbid hypertension (HTN) and obesity with those of adults reporting T2DM alone. Methods.R e s p o n -
dents to the US SHIELD survey self-reported their height, weight, comorbid conditions, hospitalizations, and outpatient visits and
completed the Short Form-12 (SF-12) and Patient Health Questionnaire (PHQ-9). Respondents reporting T2DM and HTN and
obesity (body mass index, BMI, ≥30kg/m2) were compared with a T2DM-alone group. Results.R e s p o n d e n t sw i t hT 2 D M ,H T N ,
and obesity (n = 1292) had signiﬁcantly lower SF-12 Physical and Mental Component Summary scores (37.3 and 50.9, resp.) than
T2DM-alonerespondents(n = 349)(45.8and53.5,resp.,P<0.0001).MeanPHQ-9scoresweresigniﬁcantlyhigheramongT2DM
respondentswithcomorbidHTNandobesity(5.0versus2.5,P<0.0001),indicatinggreaterdepressionburden.Respondentswith
T2DM,HTN,andobesityhadsigniﬁcantlymoreresourceutilizationwithrespecttophysicianvisitsandemergencyroomvisitsbut
not hospitalizations than respondents with T2DM alone (P = 0.03). Conclusions. SHIELD respondents with comorbid conditions
of T2DM, HTN, and obesity reported greater healthcare resource utilization, more depression symptoms, and lower quality of life
than the T2DM-alone group.
1.Background
Adults with type 2 diabetes mellitus (T2DM) are likely
to have other health conditions that may adversely impact
their health status and glycemic control [1, 2]. Hypertension
(HTN), obesity, hyperlipidemia, and cigarette smoking act
as independent modiﬁable contributors to cardiovascu-
lar disease (CVD) in patients with diabetes [3]. Current
American Diabetes Association and International Diabetes
Federation standards of medical care aim to reduce the
vascular complications through control of blood glucose,
blood pressure, and blood lipids [4, 5].
Individuals with T2DM are known to have lower quality
of life and more depressive symptomatology than those
withoutdiabetes[4–6],yettheimpactmaybepartiallydueto
comorbid conditions. Additionally, adults with diabetes have
beenshowntobefrequentconsumersofhealthcareresources
for routine physician visits, eye and foot examinations, mon-
itoring of therapy, and management of glucose and other
comorbid conditions [7, 8]. Thus, it would be hypothesized
that individuals with T2DM and comorbid conditions of
HTN and obesity would have a greater negative impact on
quality of life, greater burden of depression, and greater
use of healthcare resources if these conditions were not
monitored and treated. Notwithstanding, little information
is available regarding health outcomes among T2DM adults
with comorbid conditions of HTN and obesity who are2 Cardiology Research and Practice
treated in the community. The present study, one of the
ﬁrst investigations, was implemented to assess quality of
life, depression, and healthcare resource utilization among
adults with self-reported T2DM and comorbid HTN and
obesity, a high-risk group, compared with those among
adults reporting T2DM alone.
2. Methods
The present investigation is a cross-sectional analysis of data
from the Study to Help Improve Early evaluation and man-
agement of risk factors Leading to Diabetes (SHIELD)
comparing health outcomes (health-related quality of life
(HRQOL), depression, and healthcare resource utilization)
between respondents with T2DM and comorbid HTN and
obesity and respondents with T2DM alone. SHIELD is a
5-year, survey-based study conducted to better understand
patterns of health status, health behavior, and knowledge
and attitudes of people living with diabetes and those with
varying levels of cardiometabolic risk.
2.1. SHIELD Survey. SHIELD included an initial screening
phase to identify cases of interest in the general population
(e.g., diabetes mellitus), a baseline survey to follow up iden-
tiﬁed cases with a questionnaire about health status, health
knowledge and attitudes, and current behaviors and treat-
ments, and annual follow-up surveys. A detailed description
of the SHIELD methodology has been published previously
[9, 10].
In brief, the screening survey was mailed in April 2004
to a stratiﬁed random sample of 200,000 US households,
representativeoftheUSpopulationforgeographicresidence,
household size and income, and age of head of household
[11], identiﬁed by the Taylor Nelson Sofres National Family
Opinion (TNS NFO) panel (Greenwich, CT). All TNS
NFO surveys were voluntary, and no special incentives were
provided. A response rate of 64% (127,420 households
representing 211,097 individuals) was obtained for the
screening survey. The SHIELD study was approved by the
Quorum Review Board.
A comprehensive baseline survey was mailed in Septem-
ber-October 2004 to a representative sample of individuals,
18 years or older (n = 22,001), who were identiﬁed in the
screening survey as having self-reported T2DM or type 1
diabetes mellitus, no diabetes, or being at risk for diabetes.
Each respondent group was balanced to be representative of
that segment of the population for age, gender, geographic
region, household size, and income for the US population,
and then a random sample from each group was selected and
sentthebaselinesurvey.Aresponserateof72%wasobtained
for the baseline survey. The 2008 annual follow-up survey
collected information from 14,921 SHIELD respondents
(response rate of 71%) to identify those with the triad
conditions of T2DM, HTN, and obesity. Responses from the
2008 survey were analyzed and reported in this study.
2.2. Study Measures. Respondents were classiﬁed as having
T2DM based upon their self-report of having been told by a
doctor, nurse, or other healthcare professional that they had
T2DM. Among the T2DM respondents, two cohorts were
identiﬁed: (1) those reporting comorbid HTN plus obesity
and (2) those without a self-report of HTN and obesity.
Respondents were classiﬁed as having HTN based on their
self-report of having been told by a healthcare professional
that they had high blood pressure/HTN. Obesity was deﬁned
as a body mass index (BMI) ≥30kg/m2.
The Short Form-12 version 2 (SF-12), a validated scale,
was used to assess HRQOL. The SF-12, the short version of
the widely used SF-36, is a brief and reliable generic measure
of overall health status [12]. The SF-12 measures 8 domains
of health: physical functioning, role limitations because of
physicalhealth,bodilypain,generalhealthperceptions,vital-
ity, social functioning, role limitations because of emotional
problems, and mental health. The recall period was the past
4 weeks. SF-12 responses were scored from 0 to 100 on
the Physical Component Summary (PCS) scale and Mental
Component Summary (MCS) scale. Higher scores indicate
better HRQOL. To simplify comparisons with the general
population, norm-based scoring was used. In norm-based
scoring, scores are linearly transformed to a scale with a
mean of 50 and standard deviation (SD) of 10 for the general
population [12].
The Patient Health Questionnaire (PHQ-9) focuses on
the nine signs and symptoms of depression from the Diag-
nostic and Statistical Manual of Mental Disorders, Fourth
edition (DSM-IV) [13]. The PHQ-9 is a dual-purpose,
validated instrument that is used to establish a provisional
depressive disorder diagnosis as well as provide a symptom
severity score. Higher scores indicate increasing severity of
depression. For a diagnosis of depression, ﬁve or more items
must be scored as present more than half of the days or
nearly every day. A PHQ-9 score of 5–9 indicates minimal
depressive symptoms, a score of 10–14 is minor depression
or major depression that is mild, a score of 15–19 is major
depression, moderately severe, and a score ≥20 indicates
major depression, severe [13].
For healthcare resource utilization, respondents reported
thenumberoftimesornumberofdaysinthepast12months
they visited or stayed overnight for each type of health
facility due to their health problems. The health facilities
included hospitals, emergency room or urgent care facility,
and physician oﬃce/clinic.
2.3. Statistical Analysis. Comparisons between T2DM re-
spondents with and without comorbid conditions of HTN
andobesitywereconductedusingchi-squaretestforcategor-
ical variables and t-tests for continuous variables. Statistical
signiﬁcance was set ap r i o r ias P<0.05.
3. Results
A total of 1,395 respondents reported T2DM and comorbid
conditions of HTN and obesity (triad conditions), and 370
reported T2DM alone. An additional 680 respondents re-
ported T2DM and HTN only, and 440 had T2DM and obe-
sityonly;theserespondentswerenotincludedintheanalysis.
Respondents with the triad conditions were younger, more
often women, more nonwhite, and had higher annualCardiology Research and Practice 3
Table 1: Characteristics of SHIELD respondents with triad condi-
t i o n sv e r s u sT 2 D Ma l o n e .
Characteristics
T2DM + HTN +
Obesity
N = 1,395
T2DM alone
N = 370
Age, years, mean (SD) 61.4 (10.8)∗ 66.2 (12.9)
Women, % 65.4∗ 45.9
White, % 72.5∗ 76.8
Education, % with at least
some college 65.6 66.7
Income, % with
≥ $30,000/year 60.6∗ 72.7
Dyslipidemia, % 79.4∗ 56.9
Heart disease/heart attack, % 24.4 19.8
Stroke or TIA, % 5.5 5.7
∗P<0.01.
HTN: hypertension; SD: standard deviation; T2DM: type 2 diabetes
mellitus; TIA: transient ischemic attack.
household income than respondents with T2DM alone
(P<0.001, Table 1). Respondents with the triad conditions
were similar to respondents with T2DM alone in education
and cardiovascular disease history. Diabetes drug therapy
was similar between the groups, with 63% of each group
receiving oral antidiabetic drugs alone and 8% receiving
insulin alone. Approximately 92% of the respondents with
the triad conditions received antihypertensive therapy.
3.1. Health-Related Quality of Life. A small proportion of
respondents did not complete the SF-12; 103 (7.4%) respon-
dents with T2DM and comorbid HTN and obesity and
21 (5.7%) respondents with T2DM alone. Among those
responding, respondents with T2DM, HTN, and obesity had
signiﬁcantlylowerPCSandMCSscores(37.3and50.9,resp.)
than respondents with T2DM alone (45.8 and 53.5, resp.)
(Table 2).Physicalhealthscoreswerebelowthenorm(<50.0)
ofthegeneralpopulation forboth respondents withthe triad
conditions and those with T2DM alone.
3.2. Depression. Mean PHQ-9 scores were signiﬁcantly high-
er among T2DM respondents with comorbid HTN and obe-
sity (5.0 versus 2.5) than among respondents with T2DM
alone (P<0.001). A signiﬁcantly greater proportion of
respondents with T2DM and comorbid HTN and obesity
had mild-to-severe depression based on the PHQ-9 scores
(P<0.001) (Table 2). Additionally, 16.5% of respondents
with T2DM, HTN, and obesity had moderate-to-severe
depression, compared with 6.1% of respondents with T2DM
alone (P<0.001).
3.3. Healthcare Resource Utilization. Respondents with
T2DM, HTN, and obesity had signiﬁcantly more physician
oﬃce visits (mean = 7.7 versus 6.0) than respondents with
T2DM alone (P = 0.001) (Figure 1). More respondents with
the triad conditions had 10 or more physician visits in the
past 12months than respondents with T2DM alone (P =
Table 2: SF-12 physical and mental component summary scores
and PHQ-9 depression scores for T2DM respondents with and
without comorbid hypertension and obesity.
T2DM + HTN +
Obesity
N = 1,292
T2DM
alone
N = 349
SF-12
Physical component summary
score 37.3 (12.6)∗ 45.8 (11.7)
Mental component summary
score 50.9 (11.0)∗ 53.5 (9.3)
PHQ-9
Summary score, mean (SD) 5.0 (5.6)∗ 2.5 (4.4)
No depression, % with score
0–4 59.8 82.8
Minimal depression, % with
score 5–9 23.7 11.0
Mild depression, % with score
10–14 8.4 2.0
Moderately severe depression,
% with score 15–19 4.7 2.6
Major depression, severe, %
with score ≥20 3.4 1.5
∗P<0.001.
HTN: hypertension; SD: standard deviation; T2DM: type 2 diabetes
mellitus.
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Figure 1: Number of physician visits in the past 12 months for
T2DM respondents with and without comorbid conditions of
hypertension and obesity.
0.03); moreover, 5.7% of respondents with the triad con-
ditions versus 1.9% of T2DM-alone respondents had 20 or
more physician visits. Approximately 54% of respondents
with T2DM, HTN, and obesity visited only their primary
care physician (PCP) in the past 12 months, whereas 15%
visited their PCP and cardiologist, 19% visited their PCP
and endocrinologist, and 12% visited their PCP, cardiologist,
and endocrinologist. There was no diﬀerence in the type of
physician seen between the two T2DM groups.
Respondents with T2DM, HTN, and obesity reported
signiﬁcantlymoreemergencyroomvisits(mean = 1.9v e rs us
1.4) than respondents with T2DM alone (P = 0.02) (Table
3). More respondents with the triad conditions had 2 or4 Cardiology Research and Practice
Table 3: Healthcare resource utilization for T2DM respondents
with and without comorbid hypertension and obesity.
Resource use
T2DM + HTN +
Obesity
N = 1,395
T2DM alone
N = 370
Emergency room visits
0 visits, % 80.3 82.4
1 visit, % 11.3 12.4
2 or more visits, % 8.4 5.1
Mean (SD) for those
with ≥1 visit 1.9 (1.5)∗ 1.4 (0.8)
Hospitalizations
≥1 hospital stay in past
12 months 20.9 20.1
Median (IQR) total
number of days
hospitalized (all stays)
for those with ≥1
hospital stay
4.0 (2–8) 3.0 (2–10)
∗P = 0.02.
HTN: hypertension; SD: standard deviation; T2DM: type 2 diabetes
mellitus; IQR: interquartile range.
more emergency room visits (9%) than respondents with
T2DM alone (5%, P = 0.02). A similar proportion of
respondents (20%) reported being hospitalized at least once
in the past 12months between groups (P>0.05). There was
no signiﬁcant diﬀerence between groups in the number of
days that respondents were hospitalized (P = 0.15).
4. Discussion
SHIELD respondents with comorbid conditions of T2DM,
HTN, and obesity reported lower HRQOL, both physical
and mental health, and greater burden from depression than
respondents with T2DM alone. Healthcare resource utiliza-
tion was substantial among respondents with T2DM, HTN,
and obesity. The number of physician visits and emergency
room visits was signiﬁcantly greater among respondents
with the triad conditions, compared with T2DM-alone
respondents. Even though physician visits were frequent
among respondents with the triad conditions, less than 50%
reported seeing a cardiologist or endocrinologist over the
past 12months. The healthcare visits may be an opportunity
for patients and physicians to communicate, evaluate, and
better manage chronic disease conditions such as diabetes,
HTN, and obesity.
This study demonstrated worse health outcomes for
respondents with T2DM, HTN, and obesity, but it is
unknown in which way these three conditions interrelate
with each other and with the health outcomes. It is unclear
which event/outcome comes ﬁrst. It is possible that having
multiple health problems (T2DM, HTN, and obesity) is
overwhelming, leading to lower HRQOL and depression.
Further research is needed to determine if it is a vicious
circle of events or if the disease leads to lower HRQOL and
depression or if lower HRQOL and depression lead to the
development of T2DM, HTN, and obesity.
Previous studies have clearly established that adults with
T2DM have reduced quality of life and greater depression
compared with the general population [4–6]. However, this
is one of the ﬁrst studies to identify a group of T2DM,
that is, those with T2DM, HTN, and obesity, who have
lower quality of life and greater depression than those with
T2DM alone. It is important for healthcare providers to
identify their T2DM patients with the triad conditions, and
manage all 3 conditions to reduce the potential for lower
quality of life and depression, which may result in poorer
self-management of health and continued progression of
disease. The frequent healthcare visits to physicians provide
individuals and their physicians an opportunity for disease
management that can lead to better health outcomes. Each
physician visit should be viewed as a venue for monitoring
andreinforcingglycemiccontrol,bloodpressurecontrol,and
weight management. A previous analysis of the SHIELD data
indicated that T2DM respondents who reported exercising
regularly had higher physical and mental quality of life than
those who did not exercise regularly, and that those T2DM
respondents who tried to lose weight had higher mental
quality of life than those who did not try to lose weight [14].
Thus, if each physician visit was utilized as an opportunity
to promote regular exercise and weight management, and
patients incorporated exercise and weight management into
their daily routine, then quality of life may improve for
individuals with the triad conditions.
One of the strengths of the study is that validated in-
struments (SF-12 and PHQ-9) have been used to measure
thehealthoutcomes(HRQOLanddepression)ofindividuals
with T2DM being treated in the community. The SF-12 and
PHQ-9 are standardized, validated instruments that have
been used in numerous studies with diverse populations.
This study has some limitations that need to be con-
sidered in the interpretation of the results. The diagnosis
of diabetes, HTN, other comorbid conditions, healthcare
resource utilization, and weight were self-reported and could
not be validated with medical record review or adminis-
trative claims data. However, this bias is similar between
the two groups compared in this study. Household panels,
like the SHIELD study, tend to underrepresent the very
wealthy and very poor segments of the population and do
not include military or institutionalized individuals. HbA1c
levels were not collected in the SHIELD survey; therefore, no
information is available for diabetes control for the groups.
Diﬀerences between groups in demographic composition
(i.e., more women and higher income in the triad group)
may have been associated with increased depression and
healthcare resource utilization for the triad group since these
factors were not controlled for in this observational, real-
world outcomes study.
In conclusion, individuals with T2DM and the comorbid
conditions of HTN and obesity reported lower HRQOL and
greater depression burden than adults with T2DM alone.
These individuals with the triad conditions also had more
physician visits and emergency room visits than those with
T2DM alone. Each contact with the healthcare system couldCardiology Research and Practice 5
beanopportunitytobettermanageall3conditionstoreduce
the negative impact on quality of life. Further research is
needed to ascertain whether poor quality of life and greater
depression in respondents with T2DM, HTN, and obesity
aﬀect self-management of their diabetes and comorbid
conditions.
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